香港股市 已收市

CORT Aug 2024 37.000 call

OPR - OPR 延遲價格。貨幣為 USD。
加入追蹤清單
2.59000.0000 (0.00%)
市場開市。 截至 12:34PM EDT。
全螢幕
前收市價2.5900
開市2.5700
買盤0.0000
賣出價1.9500
拍板37.00
到期日2024-08-16
今日波幅2.4000 - 2.6200
合同範圍
成交量300
未平倉合約484
  • Zacks

    Corcept Therapeutics (CORT) is a Top-Ranked Momentum Stock: Should You Buy?

    Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

  • Reuters

    Teva sues Corcept over mifepristone 'monopoly' for rare disorder

    Teva Pharmaceuticals sued rival drugmaker Corcept Therapeutics in federal court in San Francisco on Thursday, accusing it of monopolizing the market for mifepristone-based Korlym, used to treat a rare hormonal disorder called Cushing's syndrome. The lawsuit said Corcept and specialty pharmacy Optime Care, the sole distributor of Korlym, orchestrated “a multifaceted scheme to prolong Corcept’s monopoly by stifling competition from Teva at every turn.” Teva accused Corcept of "paying bribes and kickbacks" to physicians to keep them prescribing brand Korlym.

  • Zacks

    Why Is Pacira (PCRX) Up 1.7% Since Last Earnings Report?

    Pacira (PCRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.